Trials / Completed
CompletedNCT02440555
Evaluation of the Targeted Screening of Type 2 Diabetes by Capillary Blood Glucose
Evaluation of the Targeted Screening of Type 2 Diabetes by Capillary Blood Glucose Compared to Current Screening in the Priority Health Area of Saint-Etienne and the Sainté Diabète Network.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,305 (actual)
- Sponsor
- Centre Hospitalier Universitaire de Saint Etienne · Academic / Other
- Sex
- All
- Age
- 45 Years
- Healthy volunteers
- Accepted
Summary
Type 2 diabetes is the chronic disease with the most important development in France, and particularly in the Saint-Etienne area due to his specific population. Different studies showed the interest of screening targeted on high risk population to reduce cardiovascular risks and mortality. The current screening recommandation is an opportunist targeted screening on population older than 45 years with risk factors by a fasting glucose every 3 years, and a communautaire screening targeted on population older than 45 years suffering precarity with or without risk factors by capillary blood glucose or fasting glucose. The objective of the Sainté Diabete network is to optimize the screening of diabetics, their follow-up and their treatments. Using a self-administered questionnaire during a medical visit could be a simple, cheap and efficient tool to detect diabetics as soon as possible.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | fulfill the self-administered questionnaire | Patients viewed in a pharmacy or a hospital fulfill the self-administered questionnaire before having a capillary blood glucose measurement. |
Timeline
- Start date
- 2014-11-01
- Primary completion
- 2015-03-01
- Completion
- 2015-03-01
- First posted
- 2015-05-12
- Last updated
- 2016-05-30
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02440555. Inclusion in this directory is not an endorsement.